In vivo regulation of the insulin-like growth factor system of mitogens by human chorionic gonadotropin

International Journal of Oncology

Volumn 13, Issue 3, 1998, Pages 571-575

  Huynh, Hung ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Breast cancer; Differentiation; Gene expression; Inhibition

Indexed keywords

CHORIONIC GONADOTROPIN; DIMETHYLBENZ[A]ANTHRACENE; MESSENGER RNA; MITOGENIC AGENT; SODIUM CHLORIDE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST; BREAST CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE EXPRESSION; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM;

EID: 0031829991     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.3.571     Document Type: Article

References (23)

1. Russo J and Russo IH: Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcino-genesis. Cancer Res 40: 2677-2687, 1980.
2. MacMahon B, Cole P, Liu M, Lowe CR, Mirra AP, Ravinhar H, Salber EJ, Valaoras VG and Yuasa S: Age at birth and breast cancer risk. Bull WHO 34: 209-221, 1970.
3. De Waard F and Trichopoulos D: A unifying concept of the aetiology of breast cancer. Int J Cancer 41: 666-669, 1988.
4. Henderson BE, Ross RK and Pike MC: Hormonal chemoprevention of cancer in women. Science 259: 633-638, 1993.
5. Russo IH and Russo J: Physiological bases of breast cancer prevention. Eur J Cancer Prev 2 (Suppl. 3): 101-111, 1993.
6. Russo J and Russo IH: Development pattern of human breast and susceptibility to carcinogenesis. Eur J Cancer Prev 2 (Suppl. 3): 85-100, 1993.
7. Russo J and. Russo IH: Biological and molecular bases of mammary carcinogenesis. Lab Invest 57: 112-137, 1987.
8. Russo J and Russo IH: Role of differentiation in the pathogenesis and prevention of breast cancer. Endocrin ReI Cancer 4: 7-21, 1997.
9. Russo IH, Koszalka M and Russo J: Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 82: 1286-1289, 1990.
10. Gill PS, Lunardi-Iskandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL and Gallo RC: The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Eng J Med 335: 1261-1269, 1996.
11. LeRoith D, Clemmons D, Nissley P and Rechler MM: NIH conference. Insulin-like growth factors in health and disease. Ann Int Med 116: 854-862, 1992.
12. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P and Baserga R: The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 55: 2463-2469, 1995.
13. Baserga R: The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55: 249-252, 1995.
14. Jones JI and Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995.
15. Huynh HT and Pollak M: Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine IGF binding protein 3 gene expression. Cancer Res 54: 3115-3119,1994.
16. Huynh HT, Tetenes E, Wallace L and Pollak M: In vivo inhibition of insulin-like growth factor-I gene expression by tamoxifen. Cancer Res 53: 1727-1730, 1993.
17. Murphy LJ, Bell GI, Duckworth ML and Friesen HG: Identification, characterization and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor-I. Endocrinology 121: 684-691, 1987.
18. Shimasaki S and Ling N: Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1,-2,-3,-4,-5 and -6). Prog Growth Factor Res 3: 243-266, 1991.
19. Pratt SE and Pollak M: Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of IGF binding proteins in conditioned media. Cancer Res 53:5193-5198, 1993.
20. Pollak M, Polychronakos C, Yousefi S and Richard M: Characterization of insulin-like growth factor (IGF-I) receptors of human breast cancer cells. Biochem Biophys Res Commun 154: 326-331, 1988.
21. Russo J and Russo IH: Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3: 353-364, 1994.
22. Russo IH and Russo J: Hormone prevention of mammary carcinogenesis: a new approach in anticancer research. Anticancer Res 8: 1247-1262, 1988.
23. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, et al: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491-1494, 1995.